Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical Trial.
JAMA Oncol
; 8(6): 904-909, 2022 06 01.
Article
in En
| MEDLINE
| ID: mdl-35389428
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuroendocrine Tumors
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
JAMA Oncol
Year:
2022
Document type:
Article
Country of publication: